Detalhe da pesquisa
1.
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years.
Ann Rheum Dis
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782549
2.
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies.
Ann Rheum Dis
; 82(8): 1049-1058, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37137672
3.
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.
Ann Rheum Dis
; 2023 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433575
4.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
5.
Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act!
Rheumatology (Oxford)
; 62(SI3): SI274-SI281, 2023 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871921
6.
Patient-physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation.
Rheumatology (Oxford)
; 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127964
7.
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
Mod Rheumatol
; 33(4): 657-667, 2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921235
8.
Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response.
Ann Rheum Dis
; 81(10): 1385-1391, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725296
9.
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis.
Ann Rheum Dis
; 81(7): 937-943, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470162
10.
New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis.
Rheumatology (Oxford)
; 62(1): 108-115, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416951
11.
Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
BMC Infect Dis
; 22(1): 756, 2022 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171561
12.
Pericarditis as a manifestation of IgG4-related disease.
Rheumatol Int
; 42(7): 1287-1295, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255183
13.
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
Mod Rheumatol
; 32(2): 273-283, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910203
14.
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial.
Ann Rheum Dis
; 80(8): 965-973, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811036
15.
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial.
Ann Rheum Dis
; 80(6): 727-738, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452004
16.
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.
Ann Rheum Dis
; 80(9): 1116-1123, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33832966
17.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Ann Rheum Dis
; 80(1): 71-87, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158881
18.
Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial.
Rheumatology (Oxford)
; 60(8): 3699-3708, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33434277
19.
Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trial.
Rheumatology (Oxford)
; 60(5): 2277-2287, 2021 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230526
20.
The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups.
BMC Musculoskelet Disord
; 22(1): 746, 2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461875